Cannabis Against Ovarian Cancer: Study Reveals Ability to Halt Tumors.

According to ТСН: Active components of cannabis, such as cannabidiol (CBD) and tetrahydrocannabinol (THC), have been found to suppress the growth of ovarian cancer cells and induce their self-destruction, while not harming healthy cells.

Such research results were presented by scientists from Thailand and China, who published their work in the journal Frontiers in Pharmacology. It turned out that the combination of CBD and THC is effective even against cancer cells resistant to traditional therapy. This opens new horizons for creating less toxic drugs to treat one of the most dangerous cancers in women.

Why Researchers Turned to Cannabis

Cannabis has long been used in palliative care for relieving pain, nausea, appetite loss, and psychological stress in patients with cancer. Previously, cannabis use was associated with certain risks, particularly due to smoking.

However, some scientific studies have already shown that active components of cannabis can directly affect cancer cells. CBD and THC activate cannabinoid receptors and can regulate the cell cycle, prompting further investigation into their anti-tumor properties.

What Experiments Showed

In the course of the study, scientists tested cannabidiol, tetrahydrocannabinol, and their combination on three types of cells:

• ordinary ovarian cancer cells;

• cells resistant to anti-tumor drugs;

• healthy ovarian epithelial cells.

Both separately and in combination, CBD and THC slowed the division of cancer cells, reducing their number and the size of colonies. The most pronounced effect was observed when using the combination of both compounds: it not only halted the cell cycle but also initiated apoptosis — programmed cell death of cancer cells. Healthy cells remained unharmed.

Researchers found that the mixture of CBD and THC affects the signaling pathways PI3K, AKT, and mTOR, which play a key role in the survival and proliferation of cancer cells.

Could These Compounds Become Medications?

Scientists also noted that cannabinoids can inhibit the spread of cancer cells. This opens the prospect of reducing the risk of metastasis and recurrences that often occur with ovarian cancer.

However, the integration of these compounds into medicine is still far off. Preclinical trials on animals, safety assessments for the body, and the search for ways to deliver the drugs without side effects that may arise from cannabis use are needed.

Scientists emphasize that the results are encouraging, but require further study before use in clinical practice.

As a result of the conducted research, scientists have opened new possibilities for the use of cannabinoids in the fight against ovarian cancer. Although the results are promising, the idea of integrating these compounds into medical practice will require more time and additional research. This is an important step towards developing new, less toxic approaches to treating oncological diseases that require urgent solutions.